ISoOR Insight Team. 2026. “Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025”. Journal of Organoid and Bioscience 3 (1). https://jobs.isoor.org/index.php/journal/article/view/57.